| Cas No.: | 1422253-38-0 |
| Chemical Name: | [4-[[(6S,9S,9As)-1-(benzylcarbamoyl)-2,9-dimethyl-4,7-dioxo-8-(quinolin-8-ylmethyl)-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazin-6-yl]methyl]phenyl] dihydrogen phosphate |
| Synonyms: | 43Y934BBZ6;DB15034;[4-[[(6S,9S,9As)-1-(benzylcarbamoyl)-2,9-dimethyl-4,7-dioxo-8-(quinolin-8-ylmethyl)-3,6,9,9a-tetrahy |
| SMILES: | P(=O)(O[H])(O[H])OC1C([H])=C([H])C(=C([H])C=1[H])C([H])([H])[C@@]1([H])C(N(C([H])([H])C2=C([H])C([H])=C([H])C3C([H])=C([H])C([H])=NC2=3)[C@@]([H])(C([H])([H])[H])[C@]2([H])N(C(N([H])C([H])([H])C3C([H])=C([H])C([H])=C([H])C=3[H])=O)N(C([H])([H])[H])C([H])([H])C(N21)=O)=O |
| Formula: | C33H35N6O7P |
| M.Wt: | 658.640768289566 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | PRI-724 is a selective inhibitor of the CBP/β-catenin interaction. |
| Target: | CBP/β-catenin[1] |
| In Vivo: | PRI-724 is phosphorylated-C-82 and is rapidly hydrolyzed to its active form C-82 in vivo. PRI-724 treatment reduces the fibrosis induced by CCl4 or BDL. C-82, an active form of PRI-724, inhibits the activation of isolated primary mouse quiescent hepatic stellate cells (HSCs) and promotes cell death in culture-activated HSCs[1]. |
| Animal Administration: | Mice[1] Male wild-type (C57BL/6 and Balb/c) mice aged 8 to 11 weeks or 6 to 9 months are used. CCl4 administration or BDL induced liver fibrosis model is used for this study. The animals are intraperitoneally injected with or without 0.4 mg/mouse[1]. |
| References: | [1]. Osawa Y, et al. Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice. EBioMedicine. 2015 Oct 8;2(11):1751-8. |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|